Related Experiment Video
Updated: May 3, 2026

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
Published on: December 27, 2013
Design and optimization of PLGA-based diclofenac loaded nanoparticles
Dustin L Cooper1, Sam Harirforoosh1
1Department of Pharmaceutical Sciences, Gatton College of Pharmacy, East Tennessee State University, Johnson City, Tennessee, United States of America.
This study developed diclofenac-loaded poly(lactide-co-glycolide) nanoparticles using stabilizers. Didodecyldimethylammonium bromide (DMAB) and poly vinyl alcohol (PVA) enhanced nanoparticle stability and drug entrapment efficacy.
Area of Science:
- Materials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Drug-based nanoparticle formulations offer enhanced bioavailability and reduced side effects.
- Diclofenac, a nonsteroidal anti-inflammatory drug, can cause gastrointestinal and renal side effects.
- Poly(lactide-co-glycolide) (PLGA) nanoparticles are explored for improved drug delivery.
Purpose of the Study:
- To formulate and characterize diclofenac-entrapped poly(lactide-co-glycolide) (PLGA) nanoparticles.
- To evaluate the effect of different stabilizers (PVA and DMAB) and centrifugation speeds on nanoparticle properties.
- To assess particle size, zeta potential, and drug entrapment efficiency.
Main Methods:
- Emulsion-diffusion-evaporation technique was used for nanoparticle formulation.
- Varying concentrations of poly vinyl alcohol (PVA) and didodecyldimethylammonium bromide (DMAB) were employed as stabilizers.
- Nanoparticles were characterized by particle size, zeta potential, and entrapment efficacy after centrifugation at 8,800 or 12,000 rpm.
Main Results:
- Didodecyldimethylammonium bromide (DMAB) formulations yielded the smallest particle size (108 ± 2.1 nm) and highest zeta potential (-27.71 ± 0.6 mV) at specific concentrations and 12,000 rpm centrifugation.
- Poly vinyl alcohol (PVA) formulations resulted in the smallest particle size (92.4 ± 7.6 nm) and highest zeta potential (-11.14 ± 0.5 mV) at specific concentrations and 12,000 rpm centrifugation.
- Drug entrapment efficiencies reached 77.3 ± 3.5% for DMAB and 80.2 ± 1.2% for PVA formulations.
Conclusions:
- Didodecyldimethylammonium bromide (DMAB) is recommended for enhanced nanoparticle stability during formulation.
- Poly(lactide-co-glycolide) (PLGA) based nanoparticle formulations are effective for diclofenac delivery.
- The study demonstrates successful development of diclofenac-loaded PLGA nanoparticles with optimized stabilizer concentrations and processing conditions.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Oral Drug Delivery Systems: Delayed-Release Systems
Modified-Release Drug Delivery Systems: Site-Targeted

